The Future of Regenerative Medicine is Here
Does your family have a history of….
Heart Disease
Diabetes
Arthritis
Autoimmune Diseases
Neurological Disorders
Learn how American CryoStem’s (CRYO) proprietary stem cell platform is helping patients prepare for many common medical conditions right now.
Prepare for your future TODAY!
About American CryoStem
Founded in 2008, American CryoStem Corporation, publicly traded under the symbol (CRYO) is a biotechnology pioneer, standardizing adipose tissue derived technologies for the fields of Regenerative and Personalized Medicine. CRYO is dedicated to supporting patients, and families in their pursuit of maintaining a healthy life and well-being today and in the future. The Company maintains a world class portfolio of intellectual property and patented technologies and operates a state-of-art, FDA-registered, clinical laboratory in Princeton, NJ dedicated to the collection, processing, bio-banking, culturing and differentiation of autologous adipose tissue (fat) and adipose derived stem cells (ADSCs) for use in Regenerative and Personalized Medicine.
Leveraging its laboratory platform the Company is creating a global footprint of licensed laboratory affiliates and physicians networks utilizing our operating platform. The company maintains licensed affiliates in Hong Kong, Tokyo, Japan, and Shenzhen, China
CRYO's Stem Cell Platform
An Expansive and Growing Industry
According to Allied Market Research – The global regenerative medicine market is projected to reach $30 billion by 2022. Cell therapy segment is expected to dominate the market throughout the forecast period. North America led the global market in 2015, and is expected to remain dominant during the 2015-2022.
North America is the most attractive region in the global regenerative medicines market and is expected to be the first preference for new entrants due to the increasing end-use applications in the region.
Why American CryoStem?
COMPANY HIGHLIGHTS
Strong IP portfolio of cellular products and laboratory processes addressing multi-billion dollar markets.
Ongoing relationships with leading stem cell universities and private corporations that supports a pipeline of cellular products.
Global distribution through licensed laboratories of CRYO’s products and applications (China, Hong Kong and Japan)
Institutional Review Board approvals and FDA required standard operating procedures.
Strong management and medical and scientific advisory board comprised of leading scientists and physicians.
Why Store Today?
Stem Cell Storage is the next step for a longer, healthier future. As many know, stem cells have been showing promise in the medical field, and continue to become very popular for the treatment of common diseases and medical conditions. More people are choosing to take the beneficial opportunity of storing their stem cells with American CryoStem to help insure their future.